Infection Control

U.S. Becomes 41st Country To Approve Hepatitis A Vaccine

Published in Hepatitis Weekly, May 8th, 1995

The licensing of a hepatitis A vaccine by the U.S. Food and Drug Administration (FDA) in February 1995 makes the United States the 41st country in which the vaccine is available.

The inactivated vaccine, manufactured by SmithKline Beecham Biologicals, Philadelphia, Pennsylvania, is being marketed under the name Havrix. A second vaccine against hepatitis A, made by Merck Sharp and Dohme Research Laboratories of West Point, Pennsylvania, is also under active investigation by the FDA.

According to a March 29, 1995, article in Journal of the American Medical Association, recommendations for use of the licensed vaccine are being prepared by the Hepatitis...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1995-05-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry